Migraine Clinical Trials in Phoenix, Arizona
12 recruitingPhoenix, Arizona
Showing 1–12 of 12 trials
Recruiting
Phase 3
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Episodic Migraine
Merz Therapeutics GmbH990 enrolled106 locationsNCT07018700
Recruiting
Phase 3
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Chronic Migraine
Merz Therapeutics GmbH780 enrolled106 locationsNCT07018713
Recruiting
Phase 3
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Menstrual Migraine
Pfizer723 enrolled122 locationsNCT06641466
Recruiting
Not Applicable
MMA Embolization for Refractory Chronic Migraine
Migraine
Cerenovus, Part of DePuy Synthes Products, Inc.70 enrolled9 locationsNCT06735833
Recruiting
Phase 3
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Migraine
Pfizer200 enrolled107 locationsNCT06616194
Recruiting
Phase 4
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Migraine
Mayo Clinic1,335 enrolled23 locationsNCT06972056
Recruiting
Not Applicable
Responding With Evidence and Access for Childhood Headaches
MigraineMigraine DisordersHeadache Disorders+2 more
Children's Hospital Medical Center, Cincinnati400 enrolled15 locationsNCT05889624
Recruiting
Phase 3
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Migraine
AbbVie1,059 enrolled124 locationsNCT05125302
Recruiting
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine
Migraine
AbbVie1,000 enrolled111 locationsNCT06543914
Recruiting
Phase 3
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
Migraine
AbbVie496 enrolled106 locationsNCT06417775
Recruiting
Not Applicable
Determining the Utility of a Behavioral Intervention in Chronic Migraine
MigraineChronic MigraineLifestyle Factors+3 more
Mayo Clinic60 enrolled1 locationNCT05415020
Recruiting
Phase 4
Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications
Migraine
Mayo Clinic200 enrolled1 locationNCT06401642